Brief: Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To FDA-Approved Trulance From Synergy Pharma

Cipher Pharmaceuticals

28/02/2018 12:00

Feb 28 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO : 
    * CIPHER PHARMACEUTICALS ACQUIRES EXCLUSIVE CANADIAN RIGHTS 
TO 
FDA-APPROVED TRULANCE FROM SYNERGY PHARMACEUTICALS 
    * CIPHER PHARMACEUTICALS INC - UNDER TERMS OF LICENSING 
AGREEMENT, SYNERGY WILL RECEIVE AN UPFRONT PAYMENT OF US$5.0 
MILLION 
    * CIPHER - UNDER TERMS OF LICENSING AGREEMENT, SYNERGY 
ELIGIBLE 
FOR ADDITIONAL MILESTONE PAYMENT, & ROYALTIES FROM PRODUCT SALES 
IN CANADA 
    * CIPHER PHARMACEUTICALS INC - AGREEMENT PROVIDES THAT 
SYNERGY 
WILL BE RESPONSIBLE FOR MANUFACTURING AND SUPPLYING FINISHED 
PRODUCT TO CO 
 
Source text for Eikon:  ID:nPn3HvKfHa  
Further company coverage:  CPH.TO  
 
 (Reuters.Brief@thomsonreuters.com)